CVS Health Co. (NYSE:CVS) Shares Sold by Cora Capital Advisors LLC

Cora Capital Advisors LLC lessened its stake in CVS Health Co. (NYSE:CVS) by 6.1% during the fourth quarter, according to the company in its most recent 13F filing with the SEC. The institutional investor owned 6,909 shares of the pharmacy operator’s stock after selling 449 shares during the quarter. Cora Capital Advisors LLC’s holdings in CVS Health were worth $545,000 as of its most recent filing with the SEC.

A number of other hedge funds have also bought and sold shares of CVS. Vanguard Group Inc. raised its holdings in shares of CVS Health by 0.4% during the third quarter. Vanguard Group Inc. now owns 117,162,626 shares of the pharmacy operator’s stock worth $8,180,295,000 after purchasing an additional 485,744 shares during the period. FMR LLC lifted its holdings in CVS Health by 29.1% in the third quarter. FMR LLC now owns 27,487,238 shares of the pharmacy operator’s stock worth $1,919,159,000 after acquiring an additional 6,194,441 shares during the last quarter. Northern Trust Corp boosted its stake in CVS Health by 2.2% in the third quarter. Northern Trust Corp now owns 14,214,296 shares of the pharmacy operator’s stock valued at $992,442,000 after acquiring an additional 305,564 shares during the period. Royal Bank of Canada grew its holdings in shares of CVS Health by 2.2% during the third quarter. Royal Bank of Canada now owns 14,136,920 shares of the pharmacy operator’s stock valued at $987,041,000 after purchasing an additional 303,512 shares during the last quarter. Finally, Charles Schwab Investment Management Inc. lifted its holdings in shares of CVS Health by 2.6% in the 3rd quarter. Charles Schwab Investment Management Inc. now owns 12,717,825 shares of the pharmacy operator’s stock worth $864,821,000 after purchasing an additional 324,391 shares during the last quarter. 80.66% of the stock is currently owned by institutional investors and hedge funds.

Analysts Set New Price Targets

A number of research analysts recently commented on the company. SVB Leerink started coverage on CVS Health in a research note on Monday, February 26th. They set an “outperform” rating and a $88.00 price objective for the company. Cantor Fitzgerald reaffirmed an “overweight” rating and issued a $87.00 price objective on shares of CVS Health in a report on Wednesday, April 10th. Piper Sandler boosted their target price on shares of CVS Health from $93.00 to $94.00 and gave the company an “overweight” rating in a research note on Friday, March 15th. Wells Fargo & Company dropped their price target on shares of CVS Health from $83.00 to $76.00 and set an “equal weight” rating on the stock in a research note on Monday, April 8th. Finally, Barclays started coverage on CVS Health in a research report on Wednesday, March 6th. They set an “equal weight” rating and a $78.00 price objective for the company. Four equities research analysts have rated the stock with a hold rating and twelve have given a buy rating to the company’s stock. According to data from MarketBeat.com, the stock currently has an average rating of “Moderate Buy” and a consensus target price of $89.44.

Insider Buying and Selling at CVS Health

In other CVS Health news, EVP Prem S. Shah sold 29,473 shares of CVS Health stock in a transaction that occurred on Friday, February 16th. The shares were sold at an average price of $76.95, for a total transaction of $2,267,947.35. Following the transaction, the executive vice president now directly owns 39,765 shares in the company, valued at approximately $3,059,916.75. The transaction was disclosed in a filing with the SEC, which is available at the SEC website. Insiders own 0.24% of the company’s stock.

CVS Health Price Performance

CVS stock traded down $0.15 during trading hours on Friday, hitting $67.18. 6,396,438 shares of the stock traded hands, compared to its average volume of 8,376,818. The company has a current ratio of 0.86, a quick ratio of 0.63 and a debt-to-equity ratio of 0.77. The stock has a 50-day simple moving average of $74.42 and a 200 day simple moving average of $73.67. CVS Health Co. has a one year low of $64.41 and a one year high of $83.25. The company has a market cap of $84.68 billion, a P/E ratio of 10.40, a P/E/G ratio of 0.89 and a beta of 0.52.

CVS Health (NYSE:CVS) last announced its quarterly earnings data on Wednesday, February 7th. The pharmacy operator reported $2.12 earnings per share (EPS) for the quarter, topping the consensus estimate of $2.01 by $0.11. CVS Health had a net margin of 2.33% and a return on equity of 15.25%. The company had revenue of $93.81 billion for the quarter, compared to analysts’ expectations of $90.58 billion. During the same quarter in the previous year, the company posted $1.99 EPS. The business’s revenue was up 11.9% compared to the same quarter last year. Equities analysts forecast that CVS Health Co. will post 8.31 earnings per share for the current year.

CVS Health Announces Dividend

The business also recently disclosed a quarterly dividend, which will be paid on Wednesday, May 1st. Shareholders of record on Monday, April 22nd will be issued a dividend of $0.665 per share. The ex-dividend date of this dividend is Friday, April 19th. This represents a $2.66 annualized dividend and a yield of 3.96%. CVS Health’s payout ratio is presently 41.18%.

About CVS Health

CVS Health Corporation provides health solutions in the United States. It operates through Health Care Benefits, Health Services, and Pharmacy & Consumer Wellness segments. The Health Care Benefits segment offers traditional, voluntary, and consumer-directed health insurance products and related services.